Flagship case study · AI-native product delivery

MIN–MAX Living: Human-Governed Multi-Agent Product Delivery

Designing specialized agent roles, independent review and evidence-led release controls while retaining accountable human decisions.

Multi-Agent SystemsAI Product DeliveryHuman-in-the-LoopGovernanceRelease Controls
This case study has been generalized to protect confidential information.Private URLs, repository locations, source identifiers, deployment identifiers, prompts, secrets, protected user data and owner-only controls are intentionally excluded.
Ola’s roleProduct lead and system designer for the multi-agent operating model, governance and final release decisions
Product maturityPrivate beta
ArchitectureHuman-governed multi-agent product-delivery system
Business problemThe product needed a delivery operating model that could coordinate specialized AI-agent work without allowing generated output, incomplete evidence or a single reviewer to bypass product judgment, security review, governance or protected release controls.
Strategic decisionRetain final product, risk and release decisions at explicit human approval gates.
QUALITATIVE OUTCOMEThe system expanded delivery capacity while preserving source custody, auditability, product integrity, and owner-controlled decision rights.
Relevant capabilitiesMulti-Agent Systems · AI Product Delivery · Human-in-the-Loop · Governance · Release Controls

01 · Executive summary

The product challenge in one minute.

Ola designed and governed a multi-agent product-delivery system in which specialized builder, QA, security, governance and research agents supported implementation and release readiness through protected development workflows and explicit human decision gates.

02 · Context and business problem

Why the problem mattered.

AI-assisted delivery can increase execution capacity, but a single-agent workflow concentrates implementation, validation and recommendation in one path. That structure makes it harder to preserve separation of duties, source custody, independent evidence and accountable release decisions.

Business problem

What had to change

The product needed a delivery operating model that could coordinate specialized AI-agent work without allowing generated output, incomplete evidence or a single reviewer to bypass product judgment, security review, governance or protected release controls.

03 · Users and stakeholders

The people making, supporting and governing the decision.

Primary usersProduct ownerIndependent reviewersGovernance stakeholdersPrivate-beta users

Defined how specialized builder, QA, security, governance and research agents supported evidence-led delivery under human direction.

04 · Constraints and complexity

The happy path was not the product.

Timing, partial outcomes, missing data, conflicting state and system boundaries shaped the product strategy from the beginning.

CONSTRAINT 01

A review references a different source state

CONSTRAINT 02

Independent reviewers reach conflicting conclusions

CONSTRAINT 03

A required security or governance check is missing

CONSTRAINT 04

An agent recommendation exceeds its decision boundary

CONSTRAINT 05

A QA result is stale after implementation changes

CONSTRAINT 06

Release evidence is incomplete or cannot be reproduced

05 · Product strategy

Reduce ambiguity before adding automation.

The strategy connected the operating problem to explicit states, rules, ownership, exceptions and a measurable outcome. Product definition focused on the user decision and the behavior required to make it reliable.

Ola’s product-leadership role

Product lead and system designer for the multi-agent operating model, governance and final release decisions

Owned product strategy and outcomes, agent roles, workflow architecture, operating instructions, decision gates, evidence standards, escalation boundaries, protected implementation assets and final product, risk and deployment decisions.

06 · Prioritization decision

Choose the decision that unlocks operating value.

Retain final product, risk and release decisions at explicit human approval gates.Primary strategic decision

The priority was selected because it addressed the core workflow constraint and created a foundation for safer automation, clearer ownership or more reliable downstream behavior.

See how the MIN–MAX Product Model supports strategic prioritisation and transparent trade-offs

07 · Workflow, rules and product model

The visible experience and the logic beneath it.

1Builder-agent implementation
2Independent QA
3Security analysis
4Governance review
5Research support
6Explicit handoffs
7Evidence standards
8Exact-source validation
9Human approval gates
10Protected QA and private production
Governance architectureSpecialized execution. Independent evidence. Accountable human release.
  1. 01Product directionOutcome, scope and decision rights
  2. 02Builder agentImplementation against protected source
  3. 03Independent QABehavior, regression and evidence review
  4. 04Security reviewRisk and control analysis
  5. 05Governance reviewBoundaries, provenance and policy
  6. 06Release evidenceExact-source readiness package
  7. 07Human approvalFinal product, risk and release decision
Protected sourceRepository controls
ValidationQA environment
MaturityPrivate production
Fail-closed rejection pathMissing, stale, conflicting or non-reproducible evidence returns the work to the responsible stage for revision and revalidation.

08 · Alternatives and trade-offs

Make product trade-offs explicit.

  1. 01

    Separate implementation, QA, security, governance and research responsibilities so evidence can be independently challenged.

  2. 02

    Tie validation and review evidence to the exact source state proposed for release.

  3. 03

    Protect repository workflows and use distinct QA and private-production environments.

  4. 04

    Fail closed when evidence is incomplete, stale, conflicting or outside an agent’s decision boundary.

09 · Cross-functional leadership

Align domain expertise with technical delivery.

  • Defined specialized agent responsibilities and escalation boundaries
  • Required independent QA, security and governance review
  • Established evidence requirements and exact-source validation
  • Protected repository, QA and private-production workflows
  • Retained accountable human product, risk and release decisions

Human decision rights

AI accelerates execution; accountable ownership remains human.

Ola retained final product, prioritization, risk, validation and release decisions. Specialized agents could produce implementation, analysis and review evidence, but they could not approve their own work or bypass a missing control.

The system can use third-party foundation-model services such as ChatGPT, Codex or comparable platforms. Ola’s ownership is the product architecture, workflows, configurations, implementation assets, governance, evaluations, operating model and outcomes—not the underlying foundation models.

10 · Delivery and rollout

Connect discovery to release readiness.

Owned product strategy and outcomes, agent roles, workflow architecture, operating instructions, decision gates, evidence standards, escalation boundaries, protected implementation assets and final product, risk and deployment decisions. Delivery linked product rules to user stories, measurable acceptance criteria, UAT scenarios, operational readiness and post-launch monitoring.

Explore the Discovery-to-Optimisation Process for discovery, validation and release readiness

11 · Measurement framework

Define success before development.

The confirmed result is qualitative and public-safe. Product maturity, governance controls and limitations are explicit; no unsupported productivity percentage is attached.

12 · Results

A confirmed qualitative outcome.

QUALITATIVE OUTCOME

The system expanded delivery capacity while preserving source custody, auditability, product integrity, and owner-controlled decision rights.

13 · Lessons and next decisions

Use evidence to decide what expands next.

AI-assisted product delivery becomes more trustworthy when specialization is paired with independent evidence, fail-closed controls and explicit human decision rights.Product lesson
1

Deepen agent-level observability and handoff diagnostics

2

Expand evaluation coverage for ambiguous and conflicting evidence

3

Refine private-beta learning into clearer release and product signals

Related product artifacts

Sanitized examples, built for review.

See how product thinking becomes tangible through public-safe decision tools.

View requirements, roadmap, workflow and measurement examples in the Product Artifacts Library

Let’s build what matters

Building a data-intensive, AI-enabled or healthcare workflow product?

Review the evidence or discuss how product strategy, governed AI-agent workflows, interoperability and technical fluency can support the decisions your team needs to improve.

Download résumé